Cardlytics Inc
NASDAQ:CDLX

Watchlist Manager
Cardlytics Inc Logo
Cardlytics Inc
NASDAQ:CDLX
Watchlist
Price: 1.22 USD 12.96% Market Closed
Market Cap: 66m USD

Intrinsic Value

The intrinsic value of one CDLX stock under the Base Case scenario is 3.71 USD. Compared to the current market price of 1.22 USD, Cardlytics Inc is Undervalued by 67%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

CDLX Intrinsic Value
3.71 USD
Undervaluation 67%
Intrinsic Value
Price
Base Case Scenario

Valuation History
Cardlytics Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about CDLX?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is CDLX valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Cardlytics Inc.

Explain Valuation
Compare CDLX to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about CDLX?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Cardlytics Inc

Current Assets 140.7m
Cash & Short-Term Investments 44m
Receivables 91.4m
Other Current Assets 5.3m
Non-Current Assets 152.1m
PP&E 7.5m
Intangibles 142.9m
Other Non-Current Assets 1.7m
Current Liabilities 123.7m
Accounts Payable 3.6m
Accrued Liabilities 16.4m
Short-Term Debt 46.1m
Other Current Liabilities 57.6m
Non-Current Liabilities 173.8m
Long-Term Debt 168.6m
Other Non-Current Liabilities 5.2m
Efficiency

Free Cash Flow Analysis
Cardlytics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Cardlytics Inc

Revenue
251.2m USD
Cost of Revenue
-111.8m USD
Gross Profit
139.3m USD
Operating Expenses
-189.4m USD
Operating Income
-50m USD
Other Expenses
-60.8m USD
Net Income
-110.8m USD
Fundamental Scores

CDLX Profitability Score
Profitability Due Diligence

Cardlytics Inc's profitability score is 19/100. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Strong 3Y Average Gross Margin
Gross Margin is Increasing
Declining Net Margin
19/100
Profitability
Score

Cardlytics Inc's profitability score is 19/100. The higher the profitability score, the more profitable the company is.

CDLX Solvency Score
Solvency Due Diligence

Cardlytics Inc's solvency score is 31/100. The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Long-Term Solvency
Positive Net Debt
31/100
Solvency
Score

Cardlytics Inc's solvency score is 31/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CDLX Price Targets Summary
Cardlytics Inc

Wall Street analysts forecast CDLX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CDLX is 1.66 USD with a low forecast of 1.52 USD and a high forecast of 2.1 USD.

Lowest
Price Target
1.52 USD
24% Upside
Average
Price Target
1.66 USD
36% Upside
Highest
Price Target
2.1 USD
72% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Cardlytics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for CDLX is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

CDLX Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one CDLX stock?

The intrinsic value of one CDLX stock under the Base Case scenario is 3.71 USD.

Is CDLX stock undervalued or overvalued?

Compared to the current market price of 1.22 USD, Cardlytics Inc is Undervalued by 67%.

Back to Top